Your browser doesn't support javascript.
loading
A Novel Analog of the Natural Product Fraxinellone Protects against Endogenous and Exogenous Neurotoxicants.
Bartman, Anna E; Raeisi, Mersad; Peiris, Clarence D; Jacobsen, Isabella E; Martin, David B C; Doorn, Jonathan A.
Affiliation
  • Bartman AE; Department of Pharmaceutical Sciences & Experimental Therapeutics, College of Pharmacy, University of Iowa, Iowa City, Iowa 52242, United States.
  • Raeisi M; Department of Chemistry, College of Liberal Arts & Sciences, University of Iowa, Iowa City, Iowa 52242, United States.
  • Peiris CD; Department of Chemistry, College of Liberal Arts & Sciences, University of Iowa, Iowa City, Iowa 52242, United States.
  • Jacobsen IE; Department of Chemistry, College of Liberal Arts & Sciences, University of Iowa, Iowa City, Iowa 52242, United States.
  • Martin DBC; Department of Chemistry, College of Liberal Arts & Sciences, University of Iowa, Iowa City, Iowa 52242, United States.
  • Doorn JA; Department of Pharmaceutical Sciences & Experimental Therapeutics, College of Pharmacy, University of Iowa, Iowa City, Iowa 52242, United States.
ACS Chem Neurosci ; 15(14): 2612-2622, 2024 Jul 17.
Article in En | MEDLINE | ID: mdl-38925635
ABSTRACT
Numerous insults, both endogenous (e.g., glutamate) and exogenous (e.g., pesticides), compromise the function of the nervous system and pose risk factors for damage or later disease. In previous reports, limonoids such as fraxinellone showed significant neuroprotective activity against glutamate (Glu) excitotoxicity and reactive oxygen species (ROS) production in vitro, albeit with minimal mechanistic information provided. Given these findings, a library of novel fraxinellone analogs (including analogs 1 and 2 described here) was synthesized with the goal of identifying compounds exhibiting neuroprotection against insults. Analog 2 was found to be protective against Glu-mediated excitotoxicity with a measured EC50 of 44 and 39 nM for in vitro assays using PC12 and SH-SY5Y cells, respectively. Pretreatment with analog 2 yielded rapid induction of antioxidant genes, namely, Gpx4, Sod1, and Nqo1, as measured via qPCR. Analog 2 mitigated Glu-mediated ROS. Cytoprotection could be replicated using sulforaphane (SFN), a Nrf2 activator, and inhibited via ML-385, which inhibits Nrf2 binding to regulatory DNA sequences, thereby blocking downstream gene expression. Nrf2 DNA-binding activity was demonstrated using a Nrf2 ELISA-based transcription factor assay. In addition, we found that pretreatment with the thiol N-acetyl Cys completely mitigated SFN-mediated induction of antioxidant genes but had no effect on the activity of analog 2, suggesting thiol modification is not critical for its mechanism of action. In summary, our data demonstrate a fraxinellone analog to be a novel, potent, and rapid activator of the Nrf2-mediated antioxidant defense system, providing robust protection against insults.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Reactive Oxygen Species / Neuroprotective Agents / Glutamic Acid Limits: Animals / Humans Language: En Journal: ACS Chem Neurosci Year: 2024 Document type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Reactive Oxygen Species / Neuroprotective Agents / Glutamic Acid Limits: Animals / Humans Language: En Journal: ACS Chem Neurosci Year: 2024 Document type: Article Affiliation country: United States